Drug Cost Management Report

View more issues:

Articles in July, 2002 issue of Drug Cost Management Report

• Merck-Medco Spinning Off From Parent Amid Revenue Recognition Controversy; Future Uncertain
• Defining Specialty Pharmacy: Services, Market and Players
• The FDA has approved revised labeling and prescribing information for Celebrex® - celecoxib capsules - Brief Article
• AdvancePCS Quantifies Lost Productivity On and Off the Job Due to Common Health Conditions
• Coming in August - Brief Article
• First-Tier Drug Utilization Declining Despite Push Toward Generics
• Roche's prescription weight-loss drug Xenical® - orlistat - Brief Article
• Express Scripts Examines Outcomes of Three-Tiered Pharmacy Benefit Structures
• On June 18, 2002, the FDA approved a 200 mg formulation of the antidepressant Wellbutrin SR® sustained-release tablets - bupropion HCl - Brief Article
• Prescription Solutions Helps Indiana Health Plan Tackle Polypharmacy Problems - Brief Article
• The American Association of Retired Persons - is developing antitrust class action suits against the pharmaceutical industry - Brief Article
• Blue Cross Blue Shield of Michigan
• Eckerd Health Services - Brief Article
• ACS has been awarded a one-year pharmacy benefit management contract with the Ohio Bureau of Workers' Compensation - Brief Article
• Systems Xcellence, Inc - renews contract with Serve You Custom Prescription Management - Brief Article